pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
N-acetyl cysteine amide
Retinitis Pigmentosa (Retinitis)
Nacuity Pharmaceuticals Inc
0
catalysts
N/A
N/A (ATROPINE INJECTION, 2 MG)
RAFA LABS LTD
0
catalysts
Phase 2
NA-704
Amyotrophic Lateral Sclerosis
Biomed Industries Inc
0
catalysts
Phase 1
NA-731
Traumatic Brain Injury
Biomed Industries Inc
← prev
page 111 of 231
next →
131
Pain
89
Neurology
1
0
catalysts
Phase 3
NA-831
Traneurocin
Alzheimer's Disease
Biomed Industries Inc
0
catalysts
Phase 3
NA-921
Rett Syndrome
Biomed Industries Inc
0
catalysts
Phase 2
NA-931
Obesity
Biomed Industries Inc
0
catalysts
Phase 3
NA-941
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Biomed Industries Inc
0
catalysts
Preclinical
NAFL Diseases
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)
Metallomix Inc
0
catalysts
NALMEFENE HYDROCHLORIDE
NALMEFENE HYDROCHLORIDE (NALMEFENE HYDROCHLORIDE)
Purdue Pharma LP
0
catalysts
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM (NAPROXEN AND ESOMEPRAZOLE MAGNESIUM)
Ajanta Pharma Ltd
0
catalysts
NAPROXEN ORAL SUSPENSION
NAPROXEN ORAL SUSPENSION (NAPROXEN ORAL)
NOVITIUM PHARMA
0
catalysts
NAPROXEN SODIUM AND DIPHENHYDRAMINE HCL
NAPROXEN SODIUM AND DIPHENHYDRAMINE HCL (NAPROXEN SODIUM AND DIPHENHYDRAMINE HCL)
GRANULES
0
catalysts
Phase 1
NAS-150
Idiopathic Pulmonary Fibrosis
New Amsterdam Sciences Inc
0
catalysts
Phase 2
NB-001
DiGeorge Syndrome
Nobias Therapeutics Inc
0
catalysts
Phase 2
NB-003
Gastrointestinal Stromal Tumor (GIST)
NewBay Medical Technology Co Ltd
0
catalysts
Preclinical
NBIB-233
Parkinson's Disease
$VYGR
Voyager Therapeutics, Inc.
0
catalysts
Preclinical
NBIP-2118
Obesity
$NBIX
NEUROCRINE BIOSCIENCES INC
0
catalysts
Phase 2
NBM-BMX
Metastatic Uveal Melanoma
Novelwise Pharmaceutical Corp
0
catalysts
Phase 1
NC-2400
Dyslipidemia
ABIONYX Pharma SA
0
catalysts
Phase 2
NC-410
Cervical Cancer
$NXTC
NextCure, Inc.
0
catalysts
Preclinical
NC-605
Osteogenesis Imperfecta
$NXTC
NextCure, Inc.
0
catalysts
Preclinical
NCEs
Unspecified Respiratory Disorders
Chiesi USA Inc
0
catalysts
Phase 2
NCS-01
Acute Ischemic Stroke
NC Medical Research Inc
0
catalysts
Phase 2
ND-10 ER
Myopia
Theialife Sciences Pvt Ltd
0
catalysts
Preclinical
NDC-1308
Alzheimer's Disease
Endece LLC
0
catalysts
Preclinical
NDI-5001
Kidney Disease (Nephropathy)
NephroDI Therapeutics Inc
0
catalysts
NEBIVOLOL
NEBIVOLOL (NEBIVOLOL)
HETERO LABS LTD III
0
catalysts
Preclinical
NED-170
Bile Duct Cancer (Cholangiocarcinoma)
NED Biosystems Inc
0
catalysts
Phase 2
NEO-100
Recurrent Glioblastoma Multiforme (GBM)
$NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
0
catalysts
